For Immediate Release
Contact:
mktgcomm@tams.com
PARK NICOLETTE COMPLETES PURCHASE OF 21 APLIO CV ULTRASOUND SYSTEMS FOR ENHANCED
CARDIAC APPLICATIONS
New State-of-the-Art Heart and Vascular Center Provides Cardiac Procedures For Improved
Patient Comfort
TUSTIN,
Calif., Dec. 7, 2005 – Strengthening its position as the global leader
in ultrasound technology innovation, Toshiba America Medical Systems, Inc. (TAMS)
today announced the successful installation of 21 AplioTM CV
ultrasound systems at the Park Nicolette Heart and Vascular Center in Minneapolis,
Minn. The Aplio CV, Toshiba’s all-digital ultrasound system for advanced cardiac
applications, will enable clinicians at the Heart and Vascular Center to conduct
a high-volume of echocardiographic and vascular procedures to improve the early
detection of heart failure.
The innovative
center, which houses cardiologists, vascular surgeons and interventional radiologists
in one location, performs nearly 100 ultrasound procedures daily. Each of
the 20 exam rooms will feature an Aplio CV ultrasound system. Eighteen systems will
be dedicated to cardiac echocardiography and three devoted to vascular procedures.
One system also will serve as a mobile unit.
According to
Dr. Cynthia Toher, the year-long decision making process included a detailed evaluation
of various ultrasound systems from leading vendors. “We needed an ultrasound
system that could meet our center’s specific needs from a technology and service
and support standpoint. Toshiba was able to put together a technology and support
package that met our needs perfectly.”
“The decision
by Park Nicolette to acquire our Aplio CV technology is proof of Toshiba’s superior
technology and excellent clinical support team,” said Gordon Parhar, director, Ultrasound
Business Unit, TAMS. “The fact that they selected Toshiba further reinforces
our belief that providing top-notch support after the sale is just as valuable to
customers as offering industry-leading technology.”
Aplio
CV Advanced Technology and Performance
The Aplio CV features next-generation tissue Doppler and contrast imaging technology
based on Toshiba’s Intelligent Component Architecture (ICA), which allows faster
processing of more complex data and delivers dramatically improved image quality.
ICA permits the system to perform highly complex data operations, such as Tissue
Harmonic Imaging and Pulse Subtraction techniques with frequency compounding.
For high performance
cardiac examinations as well as research and quantification studies, the Aplio CV
offers a comprehensive package for Doppler measurements and advanced clinical data
analysis, including:
• Tissue
Doppler Imaging Quantification (TDI-Q): This software performs various
analyses for TDI images, measuring myocardial viability. The Tissue Strain
Imaging (TSI) technique evaluates and clearly displays the regional myocardial strain
quantitatively during systole. Tissue tracking and angle correction for radial information,
performed with these advanced applications, further expands the range of quantitative
evaluations available. TSI, along with displacement imaging, also can be utilized
for bi-ventricular pacing. In addition to TDI-Q, Aplio CV offers Tissue Doppler
Imaging, adding TDI Harmonics, which provides higher resolution and more quantifiable
information.
• iASSISTTM:
Recipient of the Frost & Sullivan Technology Innovation Award, iASSIST features
BluetoothTM wireless network technology and allows
sonographers to improve their body positioning during exams, reducing operator strain.
In addition, iASSIST improves productivity and throughput with the use of protocol-assisted
examinations and customized programming, while allowing clinicians to define and
activate their own clinical protocols with the touch of a single button.
For more information
about the Aplio CV, Toshiba and its wide range of medical imaging products, please
visit www.medical.toshiba.com.
About
Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets,
sells, distributes and services diagnostic imaging systems, and coordinates clinical
diagnostic imaging research for all modalities in the United States. Toshiba
Medical Systems Corporation, an independent group company of Toshiba Corporation,
is a global leading provider of diagnostic medical imaging systems and comprehensive
medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information
systems. Toshiba Corporation is a leader in information and communications
systems, electronic components, consumer products, and power systems. Toshiba
has approximately 161,000 employees worldwide and annual sales of $53 billion.
AplioTM and iASSISTTM are
trademarks of Toshiba Medical Systems Corporation.
Contact Us